US EditionPublished • loading... • Updated
Development and Characterization of α-Lipoic Acid Amorphous Solid Dispersion for Improved Oral Bioavailability and Modulation of Allergic Airway Inflammation - Pharma Excipients
Summary by Pharma Excipients
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Development and Characterization of α-Lipoic Acid Amorphous Solid Dispersion for Improved Oral Bioavailability and Modulation of Allergic Airway Inflammation - Pharma Excipients
To overcome these limitations we have developed LASD using SOL to improve its oral bioavailability and therapeutic efficacy for modulating OVA-LPS.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
